- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech High Growth Potential Companies
Danish Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Feb 07, 2023
Companies with a Future performance score of at least 3, ordered by Future performance score.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALK BALK-Abelló | kr.108.50 | 5.8% | -18.7% | kr.24.0b | kr.141.80 | PE71.6x | E31.2% | 0% | ||
| BAVABavarian Nordic | kr.231.70 | 8.8% | 30.2% | kr.16.4b | kr.400.00 | PS6.8x | E32.8% | n/a | ||
| NOVO BNovo Nordisk | kr.966.10 | 2.5% | 40.4% | kr.2.2t | kr.960.52 | PE39.3x | E12.0% | 1.3% | ||
| GMABGenmab | kr.2,698.00 | 1.5% | 19.1% | kr.176.3b | kr.3,021.94 | PE31.2x | E16.5% | n/a | ||
| ZEALZealand Pharma | kr.206.20 | 0.7% | 72.4% | kr.10.6b | kr.251.67 | PS38.2x | E39.7% | n/a |
Page 1 of 1